Skip to main content
Clinical Trials/NCT06577220
NCT06577220Active, not recruitingNot Applicable

A Randomized Controlled Trial of Mailed Self-Sample HPV Testing to Increase Cervical Cancer Screening Participation Among Minority/Underserved Women in an Integrated Safety Net Healthcare System Asian/Asian American Women

Baylor College of Medicine1 site in 1 country111 target enrollmentStarted: September 28, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
111
Locations
1
Primary Endpoint
Primary screening participation

Study Overview

Brief Summary

Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women and persons with a cervix. This study is a supplement to increase representation of Asian and Asian American women in a pragmatic clinical trial that evaluates if mailing and testing self-sampled kits for high-risk human papillomavirus (HPV) can cost-effectively increase screening participation among underserved minority women in a safety-net health system.

Detailed Description

Regularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women and persons with a cervix. Using mailed self-sampling kits to test for high-risk human papillomavirus (HPV), the virus that causes cervical cancer, may overcome multiple barriers to clinic-based screening. The parent study (NCT03898167) is a randomized controlled trial to compare the effectiveness of three outreach interventions to increase primary screening participation and clinical follow-up among underscreened women a in a safety net health system. The three strategies that will be evaluated are: 1) telephone recall; 2) telephone recall with mailed self-sample HPV testing kits; and 3) telephone recall with mailed self-sample HPV testing kits and patient navigation. A supplemental accrual of Asian/Asian American persons (target n=240) was added to increase representation of this subpopulation in the parent trial.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Screening
Masking
Single (Participant)

Eligibility Criteria

Ages
30 Years to 65 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Asian ethnicity reported in the electronic health record
  • •no history of hysterectomy or cervical cancer
  • •no Pap test in the past 3.5 years or Pap/HPV co-test in the past 5.5 years
  • •patient of Harris Health System in Harris County (Houston), Texas
  • •have at least 2 visits to ambulatory care within Harris Health System in the past 5 years
  • •be currently enrolled in a healthcare coverage or financial assistance plan accepted by Harris Health System or have been enrolled in a Harris Health coverage plan in the past 12 months

Exclusion Criteria

  • •no valid telephone contact information
  • •unable to communicate in English, Vietnamese or Spanish
  • •currently pregnant
  • •history of cervical dysplasia in the past 3.5 years

Arms & Interventions

Telephone Recall

Active Comparator

Participants receive a scripted telephone recall from a trained patient navigator on behalf of Harris Health System

Intervention: Telephone Recall (Behavioral)

Mailed HPV Self-Sampling Kit

Experimental

Participants receive a scripted telephone recall from a patient navigator on behalf of Harris Health System and receive a mailed HPV self-sampling kit with a prepaid return envelope

Intervention: Telephone Recall (Behavioral)

Mailed HPV Self-Sampling Kit

Experimental

Participants receive a scripted telephone recall from a patient navigator on behalf of Harris Health System and receive a mailed HPV self-sampling kit with a prepaid return envelope

Intervention: Mailed HPV Self-Sampling Kit (Behavioral)

Mailed HPV Self-Sampling Kit + Patient Navigation

Experimental

Participants receive a scripted telephone recall and mailed self-sampling kit with a pre-paid return envelope. Within 3-5 days of the kit's mail-out, participants will receive a telephone call from a patient navigator to provide one-on-one education.

Intervention: Telephone Recall (Behavioral)

Mailed HPV Self-Sampling Kit + Patient Navigation

Experimental

Participants receive a scripted telephone recall and mailed self-sampling kit with a pre-paid return envelope. Within 3-5 days of the kit's mail-out, participants will receive a telephone call from a patient navigator to provide one-on-one education.

Intervention: Mailed HPV Self-Sampling Kit (Behavioral)

Mailed HPV Self-Sampling Kit + Patient Navigation

Experimental

Participants receive a scripted telephone recall and mailed self-sampling kit with a pre-paid return envelope. Within 3-5 days of the kit's mail-out, participants will receive a telephone call from a patient navigator to provide one-on-one education.

Intervention: Patient Navigation (Behavioral)

Outcomes

Primary Outcomes

Primary screening participation

Time Frame: [Time Frame: within 6 months of randomization

completion and return of a mailed self-sample HPV testing kit that is adequate for testing (i.e., does not produce unsatisfactory results) or attendance for clinic-based screening

Secondary Outcomes

  • Screening tests results(Time Frame: within 6 months of randomization)
  • completion of clinical follow-up among women with an abnormal screening test result(Time Frame: within 12 months of screening test result)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jane Montealegre

Associate Professor

M.D. Anderson Cancer Center

Study Sites (1)

Loading locations...

Similar Trials